TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.
Specenier, P.M., Remenar, E., Buter, J., Schrijvers, D. L., Bergamini, C., Licitra, L.F., Awada, A., Clement, P. M., Fortpied, C., Menis, J., Vermorken, J.B.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx300
Date:
June, 2017
File:
PDF, 904 KB
english, 2017